Raymond James & Associates PDL BIOPHARMA INC Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 14, 2018
SELL
N/A
-13,008 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
N/A
1,341 Added 11.49%
13,008 $36,000
Q3 2017

Nov 13, 2017
BUY
N/A
11,667
11,667 $40,000
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email